Factors influencing the efficiency of lipoplexes mediated gene transfer in lung after intravenous administration

被引:15
作者
Loisel, S [1 ]
Floch, V [1 ]
Le Gall, C [1 ]
Férec, C [1 ]
机构
[1] CHU Brest, ETSBO, Ctr Biogenet, F-29275 Brest, France
关键词
gene transfer; cationic lipids; optimization; intravenous administration;
D O I
10.1081/LPR-100108457
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The objectives of this study were to test the influence of different parameters on the in vivo cationic lipid mediated gene transfer in lung after intravenous administration. Luciferase activity was evaluated in lung tissue 24 hours after intravenous administration of different types of lipoplexes. These included lipoplexes prepared using cationic phosphonolipids or DOTAP and various amounts of plasmid DNA. Using two different plasmids we tested the influence of plasmid size on transfection efficiency in vivo. In a last series of experiments, lipoplexes were prepared using different excipients (water, NaCl or 5% glucose solution) and three injection volumes were tested. We demonstrate that chemical structure modifications such as cation substitution and increment of the aliphatic chain length significantly improve transfection efficiency. High luciferase levels are obtained by increasing lipid to DNA charge ratio and plasmid DNA dose and decreasing plasmid size. Lipoplexes prepared in physiological NaCl solution and injected using a volume of 800 mul are significantly the most effective. Cationic lipid mediated gene transfer in lung tissue after intravenous administration is influenced by factors including cationic lipid chemical structure, lipid to DNA ratio and plasmid dose. Nevertheless, plasmid size, injection volume and the excipient, used for the lipoplexes preparation, are also important factors and must be considered for an optimization of in vivo gene delivery using intravenous administration.
引用
收藏
页码:127 / 138
页数:12
相关论文
共 30 条
  • [1] The counterion influence on cationic lipid-mediated transfection of plasmid DNA
    Aberle, AM
    Bennett, MJ
    Malone, RW
    Nantz, MH
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1299 (03): : 281 - 283
  • [2] Balasubramaniam RP, 1996, GENE THER, V3, P163
  • [3] Bennett Michael J., 1996, Journal of Liposome Research, V6, P545, DOI 10.3109/08982109609031136
  • [4] Cationic lipid-mediated gene delivery to murine lung: Correlation of lipid hydration with in vivo transfection activity
    Bennett, MJ
    Aberle, AM
    Balasubramaniam, RP
    Malone, JG
    Malone, RW
    Nantz, MH
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (25) : 4069 - 4078
  • [5] Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs
    Bragonzi, A
    Boletta, A
    Biffi, A
    Muggia, A
    Sersale, G
    Cheng, SH
    Bordignon, C
    Assael, BM
    Conese, M
    [J]. GENE THERAPY, 1999, 6 (12) : 1995 - 2004
  • [6] A new DNA vehicle for nonviral gene delivery: supercoiled minicircle
    Darquet, AM
    Cameron, B
    Wils, P
    Scherman, D
    Crouzet, J
    [J]. GENE THERAPY, 1997, 4 (12) : 1341 - 1349
  • [7] FELGNER JH, 1994, J BIOL CHEM, V269, P2550
  • [8] LIPOFECTION - A HIGHLY EFFICIENT, LIPID-MEDIATED DNA-TRANSFECTION PROCEDURE
    FELGNER, PL
    GADEK, TR
    HOLM, M
    ROMAN, R
    CHAN, HW
    WENZ, M
    NORTHROP, JP
    RINGOLD, GM
    DANIELSEN, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) : 7413 - 7417
  • [9] Systemic administration of cationic phosphonolipids/DNA complexes and the relationship between formulation and lung transfection efficiency
    Floch, V
    Delépine, P
    Guillaume, C
    Loisel, S
    Chassé, S
    Le Bolc'h, G
    Gobin, E
    Leroy, JP
    Férec, C
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2000, 1464 (01): : 95 - 103
  • [10] Phosphonolipids as non-viral vectors for gene therapy
    Floch, V
    Le Bolc'h, G
    Gable-Guillaume, C
    Le Bris, N
    Yaouanc, JJ
    des Abbayes, H
    Férec, C
    Clément, JC
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1998, 33 (12) : 923 - 934